Search

everythinglearnresearchcommunity

for

Search:↓

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Anti-CD19 therapy may help treat SLE and NMOSD.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Pigmented concealing powders can improve the look of hair density for people with hair loss but need daily application and may not work well in wet conditions.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

PCOS in teens is hard to diagnose, linked to genetics and lifestyle, and managed with weight loss and medication.

Cardiovascular disease deaths decreased but still caused one-third of U.S. deaths in 2007, with high rates of hypertension, smoking, obesity, and diabetes.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Hair loss is common in IBD patients, and some medications may lower the risk.

Follicular Unit Hair Transplantation has become a less invasive procedure with natural results, suitable for certain adults with hair loss.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

The new method accurately detects illegal hair-growth drugs in dietary supplements.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Fish scale-based organic hair oil and shampoo may improve hair health and prevent damage.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.